thanks for sharing this longreach. It’s a shame that some of this detail wasn’t included in the release. It at least restores some confidence in management and the process. They should maybe just work on their comm
it’s just an annoying, slow climb back with the share price
Ann: Update on Submission of Final Module to FDA, page-21
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.035(3.13%) |
Mkt cap ! $337.4M | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.11 | $1.07 | $203.6K | 186.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2847 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 25461 | 2 |
View Market Depth
| Last trade - 14.18pm 02/09/2024 (20 minute delay) ? |
| EBR (ASX) Chart |